GLPG2737 on Top of Orkambi in Subjects With Cystic Fibrosis

NCT03474042 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: GLPG2737
DRUG: Placebo

Sponsor

Lakefront Biotherapeutics NV